Author: Diane

UChicago Celiac Disease Center Family Network is presenting Introduction to 504 Planning for Celiac Disease

March 21st at 6:30 PM CT 

Register here

On March 31, 10am – 12pm, Disease Center at Columbia University is presenting “If it is not celiac disease, what could it be? How common is seronegative celiac disease and non-celiac villous atrophy?”

The target audience is adult and pediatric physicians and physician’s assistants, nurse practitioners, fellows, dietitians and nutritionists, researchers, and patients.

This is the eighth in a series of ten bimonthly programs. Other topics are listed on the Celiac Connect Registration page.

All participants will receive a certificate of participation at the conclusion of each program. This activity is approved for AMA PRA Category 1 Credit ^TM

Register here.

Feb 28, 2023 08:00 PM

Register here.

Gluten Intolerance Group – GIG – is presenting this event.

From the registration website:

We are bringing together three experts to talk about (and answer your questions on) diet and nutrition, health and medical issues, and the social/lifestyle aspects of living gluten-free. Our panelists include:

– Dr. Ritu Verma, Medical Director of the University of Chicago Celiac Disease Center
– Erica Dermer, gluten-free lifestyle expert and advocate at Celiac and the Beast, and GIG Cares Community Relations Manager
– Jessica Lebovitz, RD, an expert in celiac disease and other gluten-related disorders, who is passionate about helping those with gastrointestinal disorders live a healthy lifestyle and enjoy food to the fullest.

Register here.

March 16, 2023, at 1 pm ET

From their website:

Join Beyond Celiac and Mark Davis, PhD, for an in-depth look at the potential mechanisms behind fatigue in autoimmune disease followed by a Q&A. Don’t miss this informative and exciting event.

Dr. Mark M. Davis is the Director of the Stanford Institute for Immunology, Transplantation and Infection (ITI), a Professor of Microbiology and Immunology, and a Howard Hughes Medical Institute Investigator. He received a B.A. from Johns Hopkins University and a Ph.D. from the California Institute of Technology. He later was a postdoctoral fellow and staff fellow at the Laboratory of Immunology at NIH and later became a faculty member in the Department of Microbiology and Immunology at Stanford University School of Medicine, where he remains today. Dr. Davis is well known for identifying many of the T-cell receptor genes, which are responsible for the ability of these cells to recognize a diverse repertoire of antigens. Other work in his laboratory pioneered studies of the biochemistry, genetics and cell biology of these molecules and T lymphocytes generally, which play a key role in orchestrating immune responses. He and his colleagues also developed a novel way of labeling specific T lymphocytes according to the molecules that they recognize (“peptide-MHC tetramers”), which is widely used in both clinical and basic immunology studies. His current research interests involve understanding the molecular interactions that underlie T-cell recognition and the challenges of human immunology, specifically a “systems level” understanding of an immune response to vaccination or infection. He has received many honors and awards, including memberships in the National Academy of Science and the Institute of Medicine, 2021 Szent-Györgyi Prize for Progress in Cancer Research, NFCR, The Paul Ehrlich Prize, The Gairdner Foundation Prize, The King Faisal Prize and the General Motors Alfred P. Sloan Prize.

March 11, 2023 11am-5pm

Register here

The University of Chicago Celiac Disease Research Center is presenting this webinar.

The following information is from their website:

Convening experts from around the country, this activity will offer insight into a variety of experiences and research as well as provide highlights of the most current information by experts relating to celiac disease and the response to the gluten-free diet. It will focus on diagnosis, gluten challenge, and healing. It will provide information about the latest research and clinical approaches, and it will educate participants about the future of this disease so they can provide better care to their patients.

Target Audience

This activity is designed for physicians, nurses, pharmacists, dietitians, researchers, other healthcare professionals, and patients dedicated to improving the diagnosis and treatment of celiac disease.

Learning Objectives

After this activity, participants will be able to:

• Discuss an evidence-based approach to diagnosing and managing the spectrum of celiac disease;
• Recall how to use the gluten-free diet centering diagnosis, gluten challenge, and healing;
• Identify diagnosis and healing complexities associated with celiac disease;
• Describe treatment plans that cover the spectrum of celiac disease and the patient’s response to the gluten-free diet;
• Name new advances in diagnosis, healing, and perspectives on the gluten challenge in celiac disease;
• Analyze why a gluten-free diet is a critical component of celiac disease treatment.